SNDX (STOCKS)
Syndax Pharmaceuticals, Inc.
$19.080000
-0.720000 (-3.64%)
Prev close: $19.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael A. Metzger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,753.38M
- Employees
- 184
- P/E (TTM)
- -7.86
- P/B (TTM)
- 116.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.55 | $-0.45 | -0.0989 | -21.92% |
|
Mar 2026 (Q1)
|
$-0.48 | $-0.59 | +0.1137 | +19.15% |
|
Dec 2025 (Q4)
|
$-0.78 | $-0.60 | -0.1842 | -30.92% |
|
Sep 2025 (Q3)
|
$-0.70 | $-0.73 | +0.0310 | +4.24% |
Financial Statements
| Revenues | $252.25M |
| Benefits Costs and Expenses | -$91.34M |
| Costs And Expenses | $457.39M |
| Nonoperating Income/Loss | -$26.59M |
| Operating Expenses | $446.42M |
| Research and Development | $261.80M |
| Other Operating Expenses | $4.94M |
| Operating Income/Loss | -$194.17M |
| Income/Loss From Continuing Operations After Tax | -$220.77M |
| Income/Loss From Continuing Operations Before Tax | $343.60M |
| Income Tax Expense/Benefit | $433.00K |
| Net Income/Loss | -$220.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$220.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$220.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.52 |
| Diluted Earnings Per Share | -$2.52 |
| Basic Average Shares | 175,340,892 |
| Diluted Average Shares | 175,340,892 |
| Assets | $703.65M |
| Current Assets | $675.04M |
| Inventory | $33.16M |
| Other Current Assets | $641.88M |
| Noncurrent Assets | $28.61M |
| Fixed Assets | $212.00K |
| Other Non-current Assets | $28.40M |
| Liabilities | $688.55M |
| Current Liabilities | $99.68M |
| Accounts Payable | $4.87M |
| Wages | $11.38M |
| Other Current Liabilities | $83.42M |
| Noncurrent Liabilities | $588.88M |
| Equity | $15.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.10M |
| Liabilities And Equity | $703.65M |
| Net Cash Flow From Operating Activities | -$220.64M |
| Net Cash Flow From Operating Activities, Continuing | -$220.64M |
| Net Cash Flow From Investing Activities | $175.48M |
| Net Cash Flow From Investing Activities, Continuing | $175.48M |
| Net Cash Flow From Financing Activities | $272.88M |
| Net Cash Flow From Financing Activities, Continuing | $272.88M |
| Net Cash Flow | $227.73M |
| Net Cash Flow, Continuing | $227.73M |
| Comprehensive Income/Loss | -$220.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$220.48M |
| Other Comprehensive Income/Loss | $289.00K |